Shares of Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $60.22 and traded as low as $55.49. Novozymes A/S shares last traded at $58.72, with a volume of 9,063 shares traded.
Novozymes A/S Price Performance
The firm has a market capitalization of $27.50 billion, a PE ratio of 37.16, a P/E/G ratio of 3.87 and a beta of 0.91. The business’s 50 day moving average is $58.04 and its two-hundred day moving average is $60.22.
Novozymes A/S Increases Dividend
The firm also recently announced a dividend, which will be paid on Wednesday, April 23rd. Investors of record on Monday, April 7th will be given a $0.3758 dividend. The ex-dividend date of this dividend is Monday, April 7th. This is a boost from Novozymes A/S’s previous dividend of $0.17. Novozymes A/S’s dividend payout ratio (DPR) is presently 94.94%.
Novozymes A/S Company Profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Read More
- Five stocks we like better than Novozymes A/S
- What Investors Need to Know About Upcoming IPOs
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- The 3 Most Talked About Investments on WallStreetBets Right Now
- The Risks of Owning Bonds
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.